Clinical Trials Logo

Clinical Trial Summary

This study will be conducted to determine the routes and rates of excretion of radio label arising from 14C-ETX2514 and to characterize metabolites of ETX2514 arising from 14C-ETX2514 administered intravenously in healthy participants.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Acinetobacter Baumannii-calcoaceticus Complex Infections
  • Infection

NCT number NCT04018950
Study type Interventional
Source Entasis Therapeutics
Contact
Status Completed
Phase Phase 1
Start date June 21, 2019
Completion date July 26, 2019

See also
  Status Clinical Trial Phase
Completed NCT03985410 - Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers Phase 1